Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

NCT00523666 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Galantamine (Reminyl®)
DRUG: Placebo/Galantamine (Reminyl®)

Sponsor

Ludwig-Maximilians - University of Munich